NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 1 mM [U-98% 15N] TipAS-1, 2 mM nosiheptide-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-4 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
2 | 2D 1H-13C HSQC aliphatic | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
3 | 3D HNCO | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
4 | 3D CBCA(CO)NH | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
5 | 3D C(CO)NH | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
6 | 3D HBHA(CO)NH | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
7 | 3D HC(CO)NH TOCSY | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
8 | 3D HCCH-TOCSY | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
9 | 3D HNHA | 1 mM [U-98% 15N] TipAS-1, 2 mM nosiheptide-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-4 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
10 | 3D 1H-15N NOESY | 1 mM [U-98% 15N] TipAS-1, 2 mM nosiheptide-2, 50 mM potassium phosphate-3, 0.02 w/v sodium azide-4 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
11 | 3D 1H-13C NOESY aliphatic | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
12 | 3D 1H-13C NOESY aromatic | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
13 | 2D 1H-1H NOESY/filter against 13C-15N | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
14 | 2D 1H-1H NOESY/filter against 13C-15N | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
15 | 2D 1H-1H TOCSY/filter against 13C-15N | 1 mM [U-99% 13C; U-99% 15N] TipAS-9, 2 mM nosiheptide-10, 50 mM potassium phosphate-11, 0.02 w/v sodium azide-12 | 100% D2O | 0.055 | | ambient | 298 | |
16 | Doublet-separated 2D 1H-15N HSQC | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
17 | Doublet-separated 2D 1H-15N HSQC | 0.8 mM [U-99% 13C; U-99% 15N] TipAS-13, 1.6 mM nosiheptide-14, 10 mM potassium phosphate-15, 10 mg/mL Pf1 phage-16 | 95% H2O/5% D2O | 0.011 | 5.9 | ambient | 298 | |
18 | J-resolved ct 13C-HSQC | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |
19 | J-resolved ct 13C-HSQC | 0.8 mM [U-99% 13C; U-99% 15N] TipAS-13, 1.6 mM nosiheptide-14, 10 mM potassium phosphate-15, 10 mg/mL Pf1 phage-16 | 95% H2O/5% D2O | 0.011 | 5.9 | ambient | 298 | |
20 | 3D CBCANH | 1 mM [U-99% 13C; U-99% 15N] TipAS-5, 2 mM nosiheptide-6, 50 mM potassium phosphate-7, 0.02 w/v sodium azide-8 | 95% H2O/5% D2O | 0.055 | 5.9 | ambient | 298 | |